• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Abuse of Minors in Clinical Studies: A Worldwide Ethical Challenge for the 21st Century

Abuse of Minors in Clinical Studies: A Worldwide Ethical Challenge for the 21st Century

Hardcover

Business GeneralMedical Reference

ISBN10: 1804411353
ISBN13: 9781804411353
Publisher: Ethics International Press, Inc
Published: May 17 2023
Pages: 164
Weight: 1.43
Height: 0.81 Width: 6.14 Depth: 9.21
Language: English

With the emergence of effective drugs and observed drug toxicities in babies, two mantras emerged: that children are therapeutic orphans, and that children are not small adults. US and EU laws demand pediatric studies as a condition for the approval of new drugs in adults. This is called Pediatric Drug Development (PDD). Although apparently reasonable, there are catches. Children are vulnerable at birth, but they grow and become bodily mature with puberty, well before coming of age. Minors are not another species. The 18th birthday, an administrative/ legal limit, does not correspond to a physiological change. Drugs treat the body, not the legal status. PDD results in pointless studies in bodily mature adolescents, and in exaggerated studies in younger minors. An originally well-intentioned concept results in thousands of questionable studies worldwide.

Also from

Rose, Klaus

Also in

Medical Reference